Spatio-Temporal Parameters of Endosomal Signaling in Cancer: Implications for New Treatment Options

Taras Stasyk1, Lukas A Huber1,2

  • 1Biocenter, Division of Cell Biology, Innsbruck Medical University, Austria.

Insights

The endo/lysosomal system regulates cell signaling and its dysfunction is linked to diseases like cancer. Understanding its spatial and temporal signaling roles may reveal new therapeutic strategies.

Area of Science:

  • Cell Biology
  • Molecular Signaling
  • Disease Pathogenesis

Background:

  • The endo/lysosomal system is crucial for cellular signaling, assembling complexes and terminating signal transduction.
  • Endocytic organelles modulate cell surface receptor signaling and generate distinct signaling outputs.
  • Dysregulation of endocytosis, recycling, degradation, and lysosomal pathways (e.g., mTORC1) contributes to diseases like cancer.

Purpose of the Study:

  • To elucidate the role of the endo/lysosomal system in cellular signaling.
  • To investigate how endocytic organelles influence signal transduction pathways.
  • To explore the potential of targeting endo/lysosomal signaling for therapeutic interventions.

Main Methods:

  • Analysis of endo/lysosomal system function in cellular signaling.
  • Investigating the spatio-temporal dynamics of signaling complex assembly.
  • Examining aberrations in pathways like mTORC1 in disease models.

Main Results:

  • The endo/lysosomal system acts as a platform for assembling and terminating signaling complexes.
  • Endocytic organelles extend and diversify signaling from cell surface receptors.
  • Aberrant endo/lysosomal signaling is implicated in various diseases, including cancer.

Conclusions:

  • A deeper understanding of endo/lysosomal signaling compartmentalization is essential.
  • Targeting these pathways offers potential for novel combinatorial therapeutic approaches.
  • Interfering with aberrant signal transduction in pathological processes is a key goal.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K